Aubrey Rankin, President, Innovation & Technology at Revance Therapeutics, Inc. (RVNC), sold 110,764 shares at $29.72 ($3.3M) on 2021-07-26, disclosed to the SEC on 2021-07-28.
Open-market sale of $3.3M RVNC by President, Innovation & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.72 | 55,382 | $1.6M | 50.0% |
| 2 | $29.72 | 55,382 | $1.6M | 50.0% |
| Total | $29.72 avg | 110,764 | $3.3M | 100% |
| Filing → |
| RVNC | SELL | 2021-07-30 | $1.6M | — | Filing → |
| RVNC | SELL | 2021-04-06 | $57 | — | Filing → |
| RVNC | SELL | 2021-03-05 | $1.7M | — | Filing → |